References
  1. Girelli D, Busti F, Brissot P, et al. Hemochromatosis classification: update and recommendations by the BIOIRON Society. Blood . 2022;139:3018.
  2. Walton C, Kelly WF, Laing I, Bu’lock DE. Endocrine abnormalities in idiopathic haemochromatosis. QJ Med. 1983;52:99.
  3. Brown S, Torrens LA. Ironing out the rough spots—cognitive impairment in haemochromatosis. BMJ Case Rep. 2012;2012.
  4. Smith LH Jr. Overview of hemochromatosis. West J Med. 1990; 153:296.
  5. Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Eng J Med. 1985;313:1256.
  6. Carniel E, Mazigh D, Mollaret HH. Expression of iron-regulated proteins in Yersinia species and their relation to virulence.Infect Immun. 1987;55:277.
  7. McNally A, Thomson NR, Reuter S, Wren BW. ‘Add, stir and reduce’: Yersinia spp.as model bacteria for pathogen evolution. Nat Rev Microbiol. 2016;14:177.
  8. Centers for Disease Control and Prevention (CDC). Red blood cell transfusions contaminated with Yersinia enterocolitica—United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR Morb Mortal Wkly Rep 1997;46:553.
  9. Bottone EJ. Yersinia enterocolitica: Revisitation of an Enduring Human Pathogen. Clin Microbiol Newsletter. 2015;37:1.
  10. Van der Heijden IM, Res PC, Wilbrink B, et al. Yersinia enterocolitica: a cause of chronic polyarthritis. Clin Infect Dis. 1997;25:831.
  11. Lee LA, Gerber AR, Lonsway DR, et al. Yersinia enterocolitica O:3 infections in infants and children, associated with the household preparation of chitterlings. N Engl J Med. 1990;322:984.
  12. El Qouqa IA, El Jarou MA, Samaha AS, et al. Yersinia enterocolitica infection among children aged less than 12 years: a case-control study. Int J Infect Dis. 2011;15:e48.
  13. Gayraud M, Scavizzi MR, Mollaret HH, et al. Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases. Clin Infect Dis. 1993;17:405.
  14. Cover TL, Aber RC. Yersinia enterocolitica. N Engl J Med. 1989;321:16.
  15. Leirisalo-Repo M. Yersinia arthritis. Acute clinical picture and long-term prognosis. Contrib Microbiol Immunol. 1987;9:145.
  16. Tsubokura M. Yersinioses other than plague. In: Laboratory Diagnosis of Infectious Diseases, Balows A, Hausler WJ Jr, Ohashi M, Turano A (Eds). Springer-Verlag, New York City. 1989. p.540.
  17. Head CB, Whitty DA, Ratnam S. Comparative study of selective media for recovery of Yersinia enterocolitica. J Clin Microbiol. 1982;16:615.
  18. Pai CH, Gillis F, Tuomanen E, Marks MI. Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis. J Pediatr. 1984;104:308.
  19. Ostroff SM, Kapperud G, Lassen J, et al. Clinical features of sporadic Yersinia enterocolitica infections in Norway. J Infect Dis. 1992;166:812.
  20. Jackson MA, Schutze GE. COMMITTEE ON INFECTIOUS DISEASES. The Use of Systemic and Topical Fluoroquinolones. Pediatrics. 2016;138.